nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Ageusia—Cisplatin—bone cancer	0.0327	0.0327	CcSEcCtD
Rimantadine—Parosmia—Epirubicin—bone cancer	0.021	0.021	CcSEcCtD
Rimantadine—Parosmia—Doxorubicin—bone cancer	0.0194	0.0194	CcSEcCtD
Rimantadine—Ageusia—Epirubicin—bone cancer	0.0168	0.0168	CcSEcCtD
Rimantadine—Rigors—Epirubicin—bone cancer	0.0167	0.0167	CcSEcCtD
Rimantadine—Sweating increased—Cisplatin—bone cancer	0.0162	0.0162	CcSEcCtD
Rimantadine—Ageusia—Doxorubicin—bone cancer	0.0156	0.0156	CcSEcCtD
Rimantadine—Rigors—Doxorubicin—bone cancer	0.0154	0.0154	CcSEcCtD
Rimantadine—Lacrimation increased—Epirubicin—bone cancer	0.0148	0.0148	CcSEcCtD
Rimantadine—Stomatitis—Cisplatin—bone cancer	0.0145	0.0145	CcSEcCtD
Rimantadine—Atrioventricular block—Epirubicin—bone cancer	0.014	0.014	CcSEcCtD
Rimantadine—Gait disturbance—Epirubicin—bone cancer	0.014	0.014	CcSEcCtD
Rimantadine—Lacrimation increased—Doxorubicin—bone cancer	0.0137	0.0137	CcSEcCtD
Rimantadine—Atrioventricular block—Doxorubicin—bone cancer	0.013	0.013	CcSEcCtD
Rimantadine—Gait disturbance—Doxorubicin—bone cancer	0.0129	0.0129	CcSEcCtD
Rimantadine—Tinnitus—Cisplatin—bone cancer	0.0124	0.0124	CcSEcCtD
Rimantadine—Mental disability—Epirubicin—bone cancer	0.0118	0.0118	CcSEcCtD
Rimantadine—Eye pain—Epirubicin—bone cancer	0.0109	0.0109	CcSEcCtD
Rimantadine—Mental disability—Doxorubicin—bone cancer	0.0109	0.0109	CcSEcCtD
Rimantadine—Tremor—Cisplatin—bone cancer	0.0109	0.0109	CcSEcCtD
Rimantadine—Eye pain—Doxorubicin—bone cancer	0.0101	0.0101	CcSEcCtD
Rimantadine—Cardiac failure—Epirubicin—bone cancer	0.0101	0.0101	CcSEcCtD
Rimantadine—Convulsion—Cisplatin—bone cancer	0.01	0.01	CcSEcCtD
Rimantadine—Ataxia—Methotrexate—bone cancer	0.00993	0.00993	CcSEcCtD
Rimantadine—Anxiety—Cisplatin—bone cancer	0.00983	0.00983	CcSEcCtD
Rimantadine—Cardiac failure—Doxorubicin—bone cancer	0.00937	0.00937	CcSEcCtD
Rimantadine—Ataxia—Epirubicin—bone cancer	0.00929	0.00929	CcSEcCtD
Rimantadine—Tachycardia—Cisplatin—bone cancer	0.00923	0.00923	CcSEcCtD
Rimantadine—Hyperhidrosis—Cisplatin—bone cancer	0.00915	0.00915	CcSEcCtD
Rimantadine—Anorexia—Cisplatin—bone cancer	0.00902	0.00902	CcSEcCtD
Rimantadine—Ataxia—Doxorubicin—bone cancer	0.0086	0.0086	CcSEcCtD
Rimantadine—Dysphagia—Epirubicin—bone cancer	0.00854	0.00854	CcSEcCtD
Rimantadine—Dyspnoea—Cisplatin—bone cancer	0.00843	0.00843	CcSEcCtD
Rimantadine—Decreased appetite—Cisplatin—bone cancer	0.00822	0.00822	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Cisplatin—bone cancer	0.00817	0.00817	CcSEcCtD
Rimantadine—Depression—Methotrexate—bone cancer	0.00812	0.00812	CcSEcCtD
Rimantadine—Stomatitis—Methotrexate—bone cancer	0.00793	0.00793	CcSEcCtD
Rimantadine—Dysphagia—Doxorubicin—bone cancer	0.0079	0.0079	CcSEcCtD
Rimantadine—Pollakiuria—Epirubicin—bone cancer	0.00789	0.00789	CcSEcCtD
Rimantadine—Feeling abnormal—Cisplatin—bone cancer	0.0078	0.0078	CcSEcCtD
Rimantadine—Stomatitis—Epirubicin—bone cancer	0.00742	0.00742	CcSEcCtD
Rimantadine—Pollakiuria—Doxorubicin—bone cancer	0.0073	0.0073	CcSEcCtD
Rimantadine—Stomatitis—Doxorubicin—bone cancer	0.00687	0.00687	CcSEcCtD
Rimantadine—Tinnitus—Methotrexate—bone cancer	0.00681	0.00681	CcSEcCtD
Rimantadine—Hypoaesthesia—Epirubicin—bone cancer	0.0068	0.0068	CcSEcCtD
Rimantadine—Asthenia—Cisplatin—bone cancer	0.00679	0.00679	CcSEcCtD
Rimantadine—Oedema peripheral—Epirubicin—bone cancer	0.00674	0.00674	CcSEcCtD
Rimantadine—Chills—Methotrexate—bone cancer	0.00656	0.00656	CcSEcCtD
Rimantadine—Diarrhoea—Cisplatin—bone cancer	0.00647	0.00647	CcSEcCtD
Rimantadine—Tinnitus—Epirubicin—bone cancer	0.00638	0.00638	CcSEcCtD
Rimantadine—Hypoaesthesia—Doxorubicin—bone cancer	0.0063	0.0063	CcSEcCtD
Rimantadine—Oedema peripheral—Doxorubicin—bone cancer	0.00623	0.00623	CcSEcCtD
Rimantadine—Chills—Epirubicin—bone cancer	0.00614	0.00614	CcSEcCtD
Rimantadine—Vomiting—Cisplatin—bone cancer	0.00601	0.00601	CcSEcCtD
Rimantadine—Rash—Cisplatin—bone cancer	0.00596	0.00596	CcSEcCtD
Rimantadine—Dermatitis—Cisplatin—bone cancer	0.00596	0.00596	CcSEcCtD
Rimantadine—Tinnitus—Doxorubicin—bone cancer	0.0059	0.0059	CcSEcCtD
Rimantadine—Tension—Epirubicin—bone cancer	0.00584	0.00584	CcSEcCtD
Rimantadine—Nervousness—Epirubicin—bone cancer	0.00578	0.00578	CcSEcCtD
Rimantadine—Chills—Doxorubicin—bone cancer	0.00568	0.00568	CcSEcCtD
Rimantadine—Nausea—Cisplatin—bone cancer	0.00562	0.00562	CcSEcCtD
Rimantadine—Cough—Methotrexate—bone cancer	0.00555	0.00555	CcSEcCtD
Rimantadine—Convulsion—Methotrexate—bone cancer	0.00551	0.00551	CcSEcCtD
Rimantadine—Agitation—Epirubicin—bone cancer	0.00547	0.00547	CcSEcCtD
Rimantadine—Tension—Doxorubicin—bone cancer	0.0054	0.0054	CcSEcCtD
Rimantadine—Nervousness—Doxorubicin—bone cancer	0.00535	0.00535	CcSEcCtD
Rimantadine—Syncope—Epirubicin—bone cancer	0.00534	0.00534	CcSEcCtD
Rimantadine—Palpitations—Epirubicin—bone cancer	0.00526	0.00526	CcSEcCtD
Rimantadine—Confusional state—Methotrexate—bone cancer	0.00523	0.00523	CcSEcCtD
Rimantadine—Loss of consciousness—Epirubicin—bone cancer	0.00523	0.00523	CcSEcCtD
Rimantadine—Cough—Epirubicin—bone cancer	0.00519	0.00519	CcSEcCtD
Rimantadine—Convulsion—Epirubicin—bone cancer	0.00516	0.00516	CcSEcCtD
Rimantadine—Hypertension—Epirubicin—bone cancer	0.00514	0.00514	CcSEcCtD
Rimantadine—Agitation—Doxorubicin—bone cancer	0.00506	0.00506	CcSEcCtD
Rimantadine—Anxiety—Epirubicin—bone cancer	0.00505	0.00505	CcSEcCtD
Rimantadine—Hyperhidrosis—Methotrexate—bone cancer	0.00502	0.00502	CcSEcCtD
Rimantadine—Dry mouth—Epirubicin—bone cancer	0.00496	0.00496	CcSEcCtD
Rimantadine—Anorexia—Methotrexate—bone cancer	0.00495	0.00495	CcSEcCtD
Rimantadine—Syncope—Doxorubicin—bone cancer	0.00494	0.00494	CcSEcCtD
Rimantadine—Confusional state—Epirubicin—bone cancer	0.0049	0.0049	CcSEcCtD
Rimantadine—Palpitations—Doxorubicin—bone cancer	0.00487	0.00487	CcSEcCtD
Rimantadine—Loss of consciousness—Doxorubicin—bone cancer	0.00484	0.00484	CcSEcCtD
Rimantadine—Cough—Doxorubicin—bone cancer	0.00481	0.00481	CcSEcCtD
Rimantadine—Shock—Epirubicin—bone cancer	0.00478	0.00478	CcSEcCtD
Rimantadine—Convulsion—Doxorubicin—bone cancer	0.00477	0.00477	CcSEcCtD
Rimantadine—Hypertension—Doxorubicin—bone cancer	0.00476	0.00476	CcSEcCtD
Rimantadine—Tachycardia—Epirubicin—bone cancer	0.00474	0.00474	CcSEcCtD
Rimantadine—Hyperhidrosis—Epirubicin—bone cancer	0.0047	0.0047	CcSEcCtD
Rimantadine—Insomnia—Methotrexate—bone cancer	0.0047	0.0047	CcSEcCtD
Rimantadine—Anxiety—Doxorubicin—bone cancer	0.00467	0.00467	CcSEcCtD
Rimantadine—Anorexia—Epirubicin—bone cancer	0.00463	0.00463	CcSEcCtD
Rimantadine—Dyspnoea—Methotrexate—bone cancer	0.00463	0.00463	CcSEcCtD
Rimantadine—Somnolence—Methotrexate—bone cancer	0.00462	0.00462	CcSEcCtD
Rimantadine—Dry mouth—Doxorubicin—bone cancer	0.00459	0.00459	CcSEcCtD
Rimantadine—Dyspepsia—Methotrexate—bone cancer	0.00457	0.00457	CcSEcCtD
Rimantadine—Confusional state—Doxorubicin—bone cancer	0.00453	0.00453	CcSEcCtD
Rimantadine—Decreased appetite—Methotrexate—bone cancer	0.00451	0.00451	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Methotrexate—bone cancer	0.00448	0.00448	CcSEcCtD
Rimantadine—Fatigue—Methotrexate—bone cancer	0.00448	0.00448	CcSEcCtD
Rimantadine—Shock—Doxorubicin—bone cancer	0.00442	0.00442	CcSEcCtD
Rimantadine—Insomnia—Epirubicin—bone cancer	0.00439	0.00439	CcSEcCtD
Rimantadine—Tachycardia—Doxorubicin—bone cancer	0.00439	0.00439	CcSEcCtD
Rimantadine—Hyperhidrosis—Doxorubicin—bone cancer	0.00435	0.00435	CcSEcCtD
Rimantadine—Dyspnoea—Epirubicin—bone cancer	0.00433	0.00433	CcSEcCtD
Rimantadine—Somnolence—Epirubicin—bone cancer	0.00432	0.00432	CcSEcCtD
Rimantadine—Anorexia—Doxorubicin—bone cancer	0.00428	0.00428	CcSEcCtD
Rimantadine—Feeling abnormal—Methotrexate—bone cancer	0.00428	0.00428	CcSEcCtD
Rimantadine—Dyspepsia—Epirubicin—bone cancer	0.00428	0.00428	CcSEcCtD
Rimantadine—Gastrointestinal pain—Methotrexate—bone cancer	0.00425	0.00425	CcSEcCtD
Rimantadine—Decreased appetite—Epirubicin—bone cancer	0.00422	0.00422	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Epirubicin—bone cancer	0.00419	0.00419	CcSEcCtD
Rimantadine—Fatigue—Epirubicin—bone cancer	0.00419	0.00419	CcSEcCtD
Rimantadine—Constipation—Epirubicin—bone cancer	0.00415	0.00415	CcSEcCtD
Rimantadine—Abdominal pain—Methotrexate—bone cancer	0.0041	0.0041	CcSEcCtD
Rimantadine—Insomnia—Doxorubicin—bone cancer	0.00407	0.00407	CcSEcCtD
Rimantadine—Dyspnoea—Doxorubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Rimantadine—Feeling abnormal—Epirubicin—bone cancer	0.004	0.004	CcSEcCtD
Rimantadine—Somnolence—Doxorubicin—bone cancer	0.004	0.004	CcSEcCtD
Rimantadine—Gastrointestinal pain—Epirubicin—bone cancer	0.00397	0.00397	CcSEcCtD
Rimantadine—Dyspepsia—Doxorubicin—bone cancer	0.00396	0.00396	CcSEcCtD
Rimantadine—Decreased appetite—Doxorubicin—bone cancer	0.00391	0.00391	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00388	0.00388	CcSEcCtD
Rimantadine—Fatigue—Doxorubicin—bone cancer	0.00388	0.00388	CcSEcCtD
Rimantadine—Constipation—Doxorubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Rimantadine—Abdominal pain—Epirubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Rimantadine—Asthenia—Methotrexate—bone cancer	0.00372	0.00372	CcSEcCtD
Rimantadine—Feeling abnormal—Doxorubicin—bone cancer	0.0037	0.0037	CcSEcCtD
Rimantadine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00368	0.00368	CcSEcCtD
Rimantadine—Abdominal pain—Doxorubicin—bone cancer	0.00355	0.00355	CcSEcCtD
Rimantadine—Diarrhoea—Methotrexate—bone cancer	0.00355	0.00355	CcSEcCtD
Rimantadine—Asthenia—Epirubicin—bone cancer	0.00349	0.00349	CcSEcCtD
Rimantadine—Dizziness—Methotrexate—bone cancer	0.00343	0.00343	CcSEcCtD
Rimantadine—Diarrhoea—Epirubicin—bone cancer	0.00332	0.00332	CcSEcCtD
Rimantadine—Vomiting—Methotrexate—bone cancer	0.0033	0.0033	CcSEcCtD
Rimantadine—Rash—Methotrexate—bone cancer	0.00327	0.00327	CcSEcCtD
Rimantadine—Dermatitis—Methotrexate—bone cancer	0.00327	0.00327	CcSEcCtD
Rimantadine—Headache—Methotrexate—bone cancer	0.00325	0.00325	CcSEcCtD
Rimantadine—Asthenia—Doxorubicin—bone cancer	0.00323	0.00323	CcSEcCtD
Rimantadine—Dizziness—Epirubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Rimantadine—Vomiting—Epirubicin—bone cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Nausea—Methotrexate—bone cancer	0.00308	0.00308	CcSEcCtD
Rimantadine—Diarrhoea—Doxorubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Rimantadine—Rash—Epirubicin—bone cancer	0.00306	0.00306	CcSEcCtD
Rimantadine—Dermatitis—Epirubicin—bone cancer	0.00306	0.00306	CcSEcCtD
Rimantadine—Headache—Epirubicin—bone cancer	0.00304	0.00304	CcSEcCtD
Rimantadine—Dizziness—Doxorubicin—bone cancer	0.00297	0.00297	CcSEcCtD
Rimantadine—Nausea—Epirubicin—bone cancer	0.00289	0.00289	CcSEcCtD
Rimantadine—Vomiting—Doxorubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Rimantadine—Rash—Doxorubicin—bone cancer	0.00283	0.00283	CcSEcCtD
Rimantadine—Dermatitis—Doxorubicin—bone cancer	0.00283	0.00283	CcSEcCtD
Rimantadine—Headache—Doxorubicin—bone cancer	0.00282	0.00282	CcSEcCtD
Rimantadine—Nausea—Doxorubicin—bone cancer	0.00267	0.00267	CcSEcCtD
